NCH 51

NCH-51 (PTACH) is a cell-permeable prodrug that is intracellularly converted to a potent HDAC inhibitor (IC₅₀ of 48 nM). PTACH is predicted to exhibit a similar HDAC binding mode as that of SAHA, interacting with the active-site zinc targeting group.